跳到正文

Foresite Capital Management VI LLC 13F 持仓 · 2026年Q2

Foresite Capital Management VI 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 23 只证券,申报市值合计 6.43 亿美元。前几大持仓:CGON(26.20%)、ALMS(18.60%)、SPTX(6.02%)。本季前 25 大持仓中:新建仓 8 只、增持 6 只、减持 1 只、清仓 2 只。

排名代码公司市值占组合股数变动
1CGONCG Oncology, Inc.$168.4M26.20%2.4M增持
2ALMSALUMIS INC.$119.5M18.60%4.2M持平
3SPTXSeaport Therapeutics, Inc.$38.7M6.02%1.8M新建仓
4DNLIDenali Therapeutics Inc.$35.9M5.59%1.4M增持
5CLDXCelldex Therapeutics, Inc.$32.7M5.09%879,713增持
6AGIOAGIOS PHARMACEUTICALS, INC.$29.1M4.53%785,000增持
7CRVSCorvus Pharmaceuticals, Inc.$27.4M4.26%1.8M持平
8PBLSParabilis Medicines, Inc.$27.3M4.26%999,044新建仓
9GHRSGH Research PLC$25.3M3.93%940,493增持
10JBIOJade Biosciences, Inc.$19.7M3.07%886,667增持
11HNGEHinge Health, Inc.$18.3M2.85%220,400持平
12KYMRKymera Therapeutics, Inc.$16.8M2.61%146,332持平
13ATAIAtaiBeckley Inc.$14.5M2.26%2.8M持平
14VSTMVerastem, Inc.$12.0M1.87%3.1M持平
15BEAMBeam Therapeutics Inc.$11.3M1.76%330,000新建仓
16NERVMinerva Neurosciences, Inc.$11.0M1.71%2.0M减持
17AVBPArriVent BioPharma, Inc.$10.5M1.63%301,341新建仓
18AURAAura Biosciences, Inc.$9.5M1.47%1.3M新建仓
19CRNXCrinetics Pharmaceuticals, Inc.$7.9M1.23%212,010持平
20RACCResearch Alliance Corp III$3.2M0.50%300,000新建仓
21ZURAZura Bio Ltd$2.7M0.41%450,000持平
22KLRAKailera Therapeutics, Inc.$826,1250.13%37,500新建仓
23IRONDisc Medicine, Inc.$70,9460.01%970新建仓
24CNTACentessa Pharmaceuticals plc$00.00%0清仓
25OKUROnKure Therapeutics, Inc.$00.00%0清仓

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR